Trends in pharmacotherapy utilization among patients with heart failure with preserved ejection fraction
Lists
Only you see this
Abstract
During the 13-year study period, the utilization of ARNIs, ARBs, ARAs, CCBs, and SGLT2i increased while the utilization of digoxin, nitrates, diuretics, and β-blockers decreased among patients with HFpEF.
BibTeX
@inproceedings{riaz2023trends,
author = {Munaza Riaz and Steven M. Smith and Eric Dietrich and David E. Winchester and Jingchuan Guo and Haesuk Park},
title = {{Trends in pharmacotherapy utilization among patients with heart failure with preserved ejection fraction}},
booktitle = {American},
year = {2023},
doi = {10.1016/j.ahjo.2023.100259},
}Loading related content...